共 50 条
- [21] Gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer: A multicenter, single-arm, phase I/II trialANNALS OF ONCOLOGY, 2024, 35 : S120 - S120Pressiani, T.Balsano, R.Giordano, L.Milella, M.Bergamo, F.Bozzarelli, S.Noventa, S.Ferrari, D.Scartozzi, M.Parra, H. J. SotoAuriemma, A.Solda, C.Zaniboni, A.Zecchetto, C.Rizzato, M. D.Rimassa, L.Santoro, A.
- [22] Multicenter Phase II Clinical Trial of Genexol-PM® with Gemcitabine in Advanced Biliary Tract CancerANTICANCER RESEARCH, 2017, 37 (03) : 1467 - 1473Kim, Jin YoungDo, Young RokSong, Hong SukCho, Yoon YoungRyoo, Hun MoBae, Sung HwaKim, Jong GwangChae, Yee SooKang, Byung WoogBaek, Jin HoKim, Min KyoungLee, Kyung HeePark, Keonuk
- [23] Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II TrialCANCERS, 2020, 12 (07) : 1 - 10Markussen, AliceJensen, Lars HenrikDiness, Laura VittrupLarsen, Finn Ole
- [24] Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Xu, QinChen, ChuanbenSun, YangHuang, ZhangzhouLin, YibinLiu, JingLi, LiLi, ZirongPan, JunpingChen, Ying
- [25] Durvalumab plus gemcitabine/cisplatin/nab-paclitaxel in resectable biliary tract cancer: A phase II, single-arm, open-label study (DurGAP)JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Li, RentaoLiu, YangLiu, YayueFu, LinlinQi, QiZhang, XihaoCui, YunlongLu, WeiLi, Huikai
- [26] Combination Therapy of Gemcitabine and Irinotecan in Advanced Biliary Tract Cancer: Phase II TrialGASTROENTEROLOGY, 2010, 138 (05) : S761 - S761Chung, Moon JaePark, SemiPark, Jeong YoupBang, SeungminPark, Seung WooSong, Si Young
- [27] Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II TrialJOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1312 - +Funt, Samuel A.Lattanzi, MichaelWhiting, KarissaAl-Ahmadie, HikmatQuinlan, ColleenTeo, Min YuenLee, Chung-HanAggen, DavidZimmerman, DanielleMcHugh, DeaglanApollo, ArlynDurdin, Trey D.Truong, HongKamradt, JeffreyKhalil, MagedLash, BradleyOstrovnaya, IrinaMcCoy, Asia S.Hettich, GraceRegazzi, AshleyJihad, MarwahRatna, NehaBoswell, AbigailFrancese, KaitlynYang, YuanquanFolefac, EdmundHerr, Harry W.Donat, S. MachelePietzak, EugeneCha, Eugene K.Donahue, Timothy F.Goh, Alvin C.Huang, William C.Bajorin, Dean F.Iyer, GopaBochner, Bernard H.Balar, Arjun V.Mortazavi, AmirRosenberg, Jonathan E.
- [28] Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trialFRONTIERS IN IMMUNOLOGY, 2025, 16Wei, JingZhang, PengfeiHu, QianchengCheng, XiaolongShen, ChaoyongChen, ZhixinZhuang, WenYin, YuanZhang, BoGou, HongfengYang, KunBi, FengLiu, Ming
- [29] Tislelizumab combined with donafenib and GEMOX as first-line treatment for advanced biliary tract cancer: A single-center, single-arm, phase II studyANNALS OF ONCOLOGY, 2024, 35 : S1458 - S1458Zhao, Y.Wang, L.Mao, A.Zhang, T.Pan, Q.Wang, L.Wang, Y.Lin, Z.Zhang, N.Zhou, J.Wang, M.Zhang, Y.Feng, Y.Ding, Z.Wang, Y.Li, Y.Wu, Z.
- [30] Phase II open, single-arm trial: Cisplatin combined with paclitaxel and doxorubicin in operable or locally advanced triple-negative breast cancerJOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Alvarado Miranda, A.Lara Medina, F. U.Arce, C.Castaneda-Soto, N.Cano Blanco, C.Aguilar Ponce, J. L.Bargallo Rocha, E.Perez-Sanchez, V.